First published April 3, 2017 - More info
Excerpt: Stuart Orkin’s research has spanned the length and breadth of hematology. Orkin (Figure 1), from the Dana-Farber Cancer Institute, identified the genetic mutations responsible for thalassemia and chronic granulomatous disease and later identified GATA-1, the master transcriptional regulator of blood cell development. His work has challenged long-held dogmas and led ...
A subscription is required for you to read this article in full. If you are a subscriber, you may sign in to continue reading.
Click here to sign into your account.
Please select one of the subscription options, which includes a low-cost option just for this article.
If you are at an institution or library and believe you should have access, please check with your librarian or administrator (more information).
Please try these troubleshooting tips.